Global Induced Pluripotent Stem Cells Market By Derived Cell Type (Fibroblasts, Hepatocytes, Keratinocytes, Amniotic Cells, and Others), By Application (Drug Development, Disease Modeling, Toxicology Research, and Tissue Engineering & Regenerative Medicine (Orthopedics, Oncology, Neurology, Diabetes, Cardiovascular and Myocardial Infarction, and Others)), By End-user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: June 2025
- Report ID: 151546
- Number of Pages: 221
- Format:
-
-
-
- Takara Bio, Inc
- STEMCELL Technologies Inc
- REPROCELL Inc
- Fate Therapeutics, Inc
- Evotec SE
- Cynata Therapeutics Limited
- Shinobi
- Axol Bioscience Ltd
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible